Professor Christian Wolfrum

Professor Christian Wolfrum

Deputy President and Provost

Professor Christian Wolfrum is Deputy President and Provost of Nanyang Technological University, Singapore. He is a distinguished scientist and academic leader with deep expertise in metabolic research.
 
As the University’s chief academic officer, he oversees college deans and school chairs to drive educational and research excellence, strengthen academic programmes, and support NTU’s commitment to holistic talent development.
 
Prior to joining NTU, ​Professor Wolfrum was Vice President for Research and a member of the Executive Board at ETH Zurich, where he was Professor of Translational Nutritional Biology. Over his 17 years at ETH Zurich, he played a pivotal role in shaping the university’s academic and research landscape. His contributions included founding the Department of Health Sciences and Technology, developing its interdisciplinary curriculum, and introducing a new medical curriculum. He was also instrumental in defining ETH Zurich’s strategic research direction, which led to the establishment of the Swiss National AI Institute and the Swiss AI Initiative.
 
From 2019 to 2022, he held a joint appointment as Parkway Pantai Professor of Healthy Ageing at the National University of Singapore. An internationally acclaimed expert in metabolic research, his work focuses on adipose tissue biology and its role in metabolism. He has published over 150 peer-reviewed articles, as well as numerous book chapters and reviews.
 

​Professor Wolfrum is a member of the German National Academy of Sciences Leopoldina and a former President of the International Conference for the Bioscience of Lipids. His research has earned multiple distinctions, including the Max Rösler Award, which honours early-career professors for outstanding achievement in research, teaching, and academic leadership. 

He holds a PhD in Biochemistry and a degree in Chemistry from the University of Münster, Germany, and completed postdoctoral research at Rockefeller University in New York. He is also an entrepreneur, having co-founded two biotechnology companies, including Glycemicon AG, an ETH spin-off focused on metabolic health.